Capital Fund Management (CFM)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Sell
13,100
-62,700
-83% -$63.6M 0.05% 472
2025
Q4
$81.5M Sell
75,800
-26,800
-26% -$25.6M 0.23% 72
2025
Q3
$78.3M Sell
102,600
-6,300
-6% -$4.69M 0.21% 94
2025
Q2
$84.9M Buy
108,900
+24,900
+30% +$19.3M 0.23% 86
2025
Q1
$69.4M Sell
84,000
-55,000
-40% -$45.8M 0.2% 136
2024
Q4
$107M Sell
139,000
-29,900
-18% -$24.8M 0.27% 74
2024
Q3
$150M Sell
168,900
-22,400
-12% -$20.1M 0.41% 34
2024
Q2
$173M Sell
191,300
-43,200
-18% -$34.6M 0.51% 13
2024
Q1
$182M Sell
234,500
-57,500
-20% -$40.9M 0.53% 12
2023
Q4
$170M Buy
292,000
+139,100
+91% +$81.2M 0.46% 19
2023
Q3
$82.1M Buy
152,900
+74,900
+96% +$38.6M 0.28% 77
2023
Q2
$36.6M Sell
78,000
-27,500
-26% -$11.5M 0.15% 183
2023
Q1
$36.2M Buy
105,500
+68,300
+184% +$23M 0.17% 143
2022
Q4
$13.6M Sell
37,200
-54,800
-60% -$19.4M 0.09% 308
2022
Q3
$29.7M Buy
92,000
+69,500
+309% +$22M 0.23% 107
2022
Q2
$7.3M Sell
22,500
-5,900
-21% -$1.77M 0.07% 408
2022
Q1
$8.13M Sell
28,400
-57,200
-67% -$14.7M 0.07% 398
2021
Q4
$23.6M Buy
85,600
+3,000
+4% +$761K 0.17% 153
2021
Q3
$19.1M Buy
82,600
+54,800
+197% +$13.5M 0.14% 183
2021
Q2
$6.38M Sell
27,800
-300
-1% -$60.3K 0.05% 480
2021
Q1
$5.25M Buy
+28,100
New +$5.5M 0.06% 407
2020
Q4
Sell
-21,200
Closed -$3.14M 1436
2020
Q3
$3.14M Sell
21,200
-5,100
-19% -$789K 0.04% 496
2020
Q2
$4.32M Sell
26,300
-143,900
-85% -$22.1M 0.07% 327
2020
Q1
$23.6M Buy
170,200
+68,400
+67% +$9.4M 0.37% 55
2019
Q4
$13.4M Buy
101,800
+44,900
+79% +$5.2M 0.11% 245
2019
Q3
$6.36M Buy
56,900
+21,900
+63% +$2.44M 0.06% 406
2019
Q2
$3.88M Sell
35,000
-133,300
-79% -$15.7M 0.04% 598
2019
Q1
$21.8M Buy
168,300
+27,800
+20% +$3.38M 0.2% 142
2018
Q4
$16.3M Buy
140,500
+93,300
+198% +$10.4M 0.14% 173
2018
Q3
$5.07M Buy
47,200
+43,700
+1,249% +$4.37M 0.03% 759
2018
Q2
$299K Sell
3,500
-3,500
-50% -$287K ﹤0.01% 1787
2018
Q1
$542K Sell
7,000
-28,800
-80% -$2.32M ﹤0.01% 1436
2017
Q4
$3.02M Buy
35,800
+31,800
+795% +$2.71M 0.02% 837
2017
Q3
$342K Sell
4,000
-13,200
-77% -$1.08M ﹤0.01% 1286
2017
Q2
$1.42M Sell
17,200
-74,600
-81% -$6.09M 0.01% 812
2017
Q1
$7.72M Buy
91,800
+58,700
+177% +$4.7M 0.06% 349
2016
Q4
$2.44M Sell
33,100
-6,100
-16% -$454K 0.02% 706
2016
Q3
$3.15M Sell
39,200
-22,400
-36% -$1.79M 0.03% 615
2016
Q2
$4.85M Buy
61,600
+49,500
+409% +$3.73M 0.05% 450
2016
Q1
$871K Sell
12,100
-156,100
-93% -$11.8M 0.01% 939
2015
Q4
$14.2M Sell
168,200
-29,000
-15% -$2.41M 0.15% 189
2015
Q3
$16.5M Buy
197,200
+107,400
+120% +$9.07M 0.18% 143
2015
Q2
$7.5M Buy
89,800
+17,600
+24% +$1.34M 0.1% 287
2015
Q1
$5.25M Sell
72,200
-71,900
-50% -$5.12M 0.07% 334
2014
Q4
$9.94M Sell
144,100
-205,100
-59% -$13.8M 0.12% 239
2014
Q3
$22.6M Buy
349,200
+62,500
+22% +$3.96M 0.25% 85
2014
Q2
$17.8M Buy
286,700
+68,300
+31% +$4.08M 0.19% 129
2014
Q1
$12.9M Buy
218,400
+109,800
+101% +$6.13M 0.16% 148
2013
Q4
$5.54M Buy
108,600
+49,900
+85% +$2.5M 0.07% 348
2013
Q3
$2.95M Buy
58,700
+30,900
+111% +$1.62M 0.04% 507
2013
Q2
$1.37M Buy
+27,800
New +$1.51M 0.02% 720

Other funds holding LLY

Capital Fund Management (CFM)'s LLY Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in Eli Lilly (LLY) in Q1 2026: 189,558 shares worth $174M. The stake represents 0.79% of the portfolio and ranks #8 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in LLY as recently as Q3 2025.

Capital Fund Management (CFM) first reported a position in LLY in Q2 2013 and has held it in 18 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Capital Fund Management (CFM) held 189,558 shares of Eli Lilly worth $174M as of Q1 2026.
  • Eli Lilly was a new Capital Fund Management (CFM) position in Q1 2026.
  • Eli Lilly made up 0.79% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #8 holding.
  • Capital Fund Management (CFM) first reported a position in Eli Lilly in Q2 2013 and has held it in 18 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.